The putative 5-HT(1A) receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT(1A) receptor agonist flesinoxan in pigeons

European Journal of Pharmacology

Volumn 325, Issue 2-3, 1997, Pages 145-153

  Mos, Jan ^a   Van Hest, Annemiek ^b   Van Drimmelen, Marlies ^a   Herremans, Arnoud H J ^a   Olivier, Berend ^a,c  

^a Solvay Pharmaceuticals Inc   (Netherlands)

^b Tramarko   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

5 HT(1A) receptor; Drug discrimination; DU125530; Pigeon

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 2 DIPROPYLAMINO 5 FLUORO 8 HYDROXYTETRALIN; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; BUSPIRONE; DU 125530; ELTOPRAZINE; FLESINOXAN; FLUVOXAMINE; IPSAPIRONE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; PINDOLOL; POSTSYNAPTIC RECEPTOR; RECEPTOR SUBTYPE; SEROTONIN 1A RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG; 1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 1-(3-CHLOROPHENYL)PIPERAZINE; 1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE; 4 (BENZODIOXAN 5 YL) 1 (INDAN 2 YL)PIPERAZINE; 4-(BENZODIOXAN-5-YL)-1-(INDAN-2-YL)PIPERAZINE; 5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDINYL)1H INDOLE; 5-METHOXY 3-(1,2,3,6-TETRAHYDRO-4-PYRIDINYL)1H INDOLE; INDOLE DERIVATIVE; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; SEROTONIN 1 RECEPTOR; THIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; DRUG RECEPTOR BINDING; NONHUMAN; ORAL DRUG ADMINISTRATION; PIGEON; PRIORITY JOURNAL; REINFORCEMENT; ANIMAL; DISCRIMINATION LEARNING; DRUG EFFECT; PHYSIOLOGY; PIGEONS AND DOVES;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BUSPIRONE; COLUMBIDAE; DISCRIMINATION LEARNING; FLUVOXAMINE; INDOLES; PINDOLOL; PIPERAZINES; PYRIDINES; PYRIMIDINES; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; THIAZOLES;

EID: 0030611699     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00131-3     Document Type: Article

References (41)

1. 1 receptor subtype coupled to the inhibition of adenylase cyclase, Proc. Natl. Acad. Sci. USA 90, 408.
2. 2 agonists in rats, Pharmacol. Toxicol. 64, 165.
3. 1A drugs in the pigeon, Drug Dev. Res. 26, 299.
4. 3 Antagonists and Benzodiazepines, eds. R.J. Rodgers and S.J. Cooper (John Wiley and Sons, New York, NY) p. 59.
5. 1A receptor antagonists BMY 7378 and NAN-190, Eur. J. Pharmacol. 217, 163.
6. Barrett, J.E. and J.M. Witkin, 1991, Buspirone in animal models of anxiety, in: Buspirone: Mechanisms and Clinical Aspects, eds. G. Tunnicliff, A. Eison and D. Taylor (Academic Press, Orlando, FL) p. 37.
7. 1A compound flesinoxan, J. Psychopharmacol. 3, 64.
8. 1A antagonist research, Drugs Future 18, 631.
9. 1A receptor antagonists: utility as research tools and therapeutic agents, Trends Pharmacol. Sci. 14, 441.
10. 1A receptor antagonist, Behav. Brain Res. 73, 337.
11. 1A receptors, Br. J. Pharmacol. 86, 601P.
12. Glennon, R.A., 1990, Serotonin receptors: clinical implications, Neurosci. Biobehav. Rev. 14, 35.
13. 1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), Eur. J. Pharmacol. 154, 339.
14. 1A serotonin antagonist, Drug Dev. Res. 16, 335.
15. 1A receptors in rat brain membranes, Eur. J. Pharmacol. 288, 173.
16. 1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol, J. Pharmacol. Exp. Ther. 265, 707.
17. Hoyer, D. and D.N. Middlemiss, 1989, Species differences in the pharmacology of terminal 5-HT autoreceptors in the mammalian brain, Trends Pharmacol. Sci. 10, 130.
18. Humphrey, P.P.A., P. Hartig and D. Hoyer, 1993, A proposed new nomenclature for 5-HT receptors, Trends Pharmacol. Sci. 14, 233.
19. Middlemiss, D.N. and M.D. Tricklebank, 1992, Centrally active 5-HT receptor agonists and antagonists, Neurosci. Biobehav. Rev. 16, 75.
20. 1A receptor ligand which acts as an agonist and an antagonist at presynaptic and postsynaptic sites respectively, Eur. J. Pharmacol. 230, 99.
21. 1A receptor antagonist (S)-UH-301 prevents (R)-8-OH-DPAT-induced decrease in interstitial concentrations of serotonin in the rat hippocampus, Eur. J. Pharmacol. 216, 373.
22. Peroutka, S.J., 1988, 5-Hydroxytryptamine receptor subtypes, Annu. Rev. Neurosci. 11, 45.
23. 2-adrenoceptor antagonist idazoxan, Psychopharmacology 99, 117.
24. 1A receptors, Psychopharmacology 108, 85.
25. Schipper, J., M. Tulp, H. Sybesma, F. Krijzer, J. Mos, J. Van der Heyden and B. Olivier, 1990, Preclinical evaluation of flesinoxan as a potential anxiolytic and antidepressant drug, Eur. J. Pharmacol. 183, 2059.
26. Schipper, J., M. Tulp, H.S. Berkelmans, J. Mos, J. Van der Heyden and B. Olivier, 1991, Preclinical pharmacology of flesinoxan: a potential anxiolytic and antidepressant drug, Hum. Psychopharmacol. Clin. Exp. 6, S53.
27. 1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus, Br. J. Pharmacol. 95, 975.
28. 1A receptors, Third IUPHAR Satellite Meeting on Serotonin 92.
29. Tatham, T.A. and K.R. Zurn, 1989, The MED-PC experimental apparatus programming system, Behav. Res. Meth. Instrum. Comp. 21, 294.
30. 1A receptor, Eur. J. Pharmacol. 133, 47.
31. Van Hest, A., M. Van Drimmelen and B. Olivier, 1992, Flesinoxan shows antidepressant activity in a DRL 72-s screen, Psychopharmacology 107, 474.
32. 1 receptors in the vertebrate brain: regional distribution examined by autoradiography, Naunyn-Schmiedeberg's Arch. Pharmacol. 340, 486.
33. 1D receptors in guinea-pig and pigeon brain: radioligand binding and biochemical studies, Naunyn-Schmiedeberg's Arch. Pharmacol. 340, 479.
34. Winter, J.C., 1988, Generalization of the discriminative stimulus properties of 8-OH-DPAT and ipsapirone to yohimbine, Pharmacol. Biochem. Behav. 29, 193.
35. Winter, J.C. and R.A. Rabin, 1989, Yohimbine and serotonergic agonists: stimulus properties and receptor binding, Drug Dev. Res. 16, 327.
36. Winter, J.C. and R.A. Rabin, 1992, Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination, J. Pharmacol. Exp. Ther. 263, 682.
37. Ybema, C.E., J.L. Slangen, B. Olivier and J. Mos, 1990, Discriminative stimulus properties of flesinoxan, Pharmacol. Biochem. Behav. 35, 781.
38. Ybema, C.E., I. Van den Broek, J.L. Slangen, B. Olivier and J. Mos, 1991, Further study on the discriminative stimulus properties of flesinoxan, in: Animal Models in Psychopharmacology, eds. B. Olivier, J. Mos and J.L. Slangen (Birkhäuser Verlag, Basel) p. 387.
39. Ybema, C.E., J.L. Slangen, B. Olivier and J. Mos, 1993, Dose-dependent discriminative stimulus properties of 8-OH-DPAT, Behav. Pharmacol. 4, 610.
40. 1A receptor agonist flesinoxan, Eur. J. Pharmacol. 256, 141.
41. 1A antagonists and PCPA, Pharmacol. Biochem. Behav. 47, 957.